Antigen Information
General Information of This Antigen
| Antigen ID | TAR0PQIJF |
|||||
|---|---|---|---|---|---|---|
| Antigen Name | Cadherin-17 (CDH17) |
|||||
| Gene Name | CDH17 |
|||||
| Synonym | Intestinal peptide-associated transporter HPT-1;Liver-intestine cadherin |
|||||
| Sequence |
MILQAHLHSLCLLMLYLATGYGQEGKFSGPLKPMTFSIYEGQEPSQIIFQFKANPPAVTF
ELTGETDNIFVIEREGLLYYNRALDRETRSTHNLQVAALDANGIIVEGPVPITIKVKDIN DNRPTFLQSKYEGSVRQNSRPGKPFLYVNATDLDDPATPNGQLYYQIVIQLPMINNVMYF QINNKTGAISLTREGSQELNPAKNPSYNLVISVKDMGGQSENSFSDTTSVDIIVTENIWK APKPVEMVENSTDPHPIKITQVRWNDPGAQYSLVDKEKLPRFPFSIDQEGDIYVTQPLDR EEKDAYVFYAVAKDEYGKPLSYPLEIHVKVKDINDNPPTCPSPVTVFEVQENERLGNSIG TLTAHDRDEENTANSFLNYRIVEQTPKLPMDGLFLIQTYAGMLQLAKQSLKKQDTPQYNL TIEVSDKDFKTLCFVQINVIDINDQIPIFEKSDYGNLTLAEDTNIGSTILTIQATDADEP FTGSSKILYHIIKGDSEGRLGVDTDPHTNTGYVIIKKPLDFETAAVSNIVFKAENPEPLV FGVKYNASSFAKFTLIVTDVNEAPQFSQHVFQAKVSEDVAIGTKVGNVTAKDPEGLDISY SLRGDTRGWLKIDHVTGEIFSVAPLDREAGSPYRVQVVATEVGGSSLSSVSEFHLILMDV NDNPPRLAKDYTGLFFCHPLSAPGSLIFEATDDDQHLFRGPHFTFSLGSGSLQNDWEVSK INGTHARLSTRHTEFEEREYVVLIRINDGGRPPLEGIVSLPVTFCSCVEGSCFRPAGHQT GIPTVGMAVGILLTTLLVIGIILAVVFIRIKKDKGKDNVESAQASEVKPLRS Click to Show/Hide
|
|||||
| Function |
Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. LI-cadherin may have a role in the morphological organization of liver and intestine. Involved in intestinal peptide transport.
Click to Show/Hide
|
|||||
| Uniprot Entry | ||||||
| HGNC ID | ||||||
| KEGG ID | ||||||
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
Anti-CDH17 antibody
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AMT-676 |
Exatecan |
DNA topoisomerase 1 (TOP1) |
T1000 |
||
HDM2017 |
CPT-derivative payloads |
DNA topoisomerase 1 (TOP1) |
Undisclosed |
[1] | |
yL217 |
YL0010014 |
DNA topoisomerase 1 (TOP1) |
VK*G-NHCH2-O linker |
||
dB-1324 |
Undisclosed |
Undisclosed |
Undisclosed |
||
hS-20110 |
HS-9265 |
DNA topoisomerase 1 (TOP1) |
Undisclosed |
||
sIM0609 |
CPT116 |
DNA topoisomerase 1 (TOP1) |
A cleavable linker |
Anti-CDH17 mAb
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
cM518D1 |
Undisclosed |
Undisclosed |
Undisclosed |
||
mRG007 |
Exatecan |
DNA topoisomerase 1 (TOP1) |
Undisclosed |
Anti-CDH17 mAb ARB102
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
ARB102-IR700 |
IRDye 700DX |
Undisclosed |
Undisclosed |
[2] |
Fully humanized anti-CDH17 monoclonal antibody
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
BSI-721 |
Monomethyl auristatin E |
Undisclosed |
Undisclosed |
[3] |
humanized CDH17 IgG1 monoclonal antibody
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
LBL-054 |
Undisclosed |
Undisclosed |
Undisclosed |
[4] | |
LBL-054-Dxd |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
Undisclosed |
[4] |
LM-150
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
LM-350 |
LDX2 |
DNA topoisomerase 1 (TOP1) |
A cleavable linker |
[5] |
Mab0727
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
7MW4911 |
Mtoxin |
DNA topoisomerase 1 (TOP1) |
A cleavable disulfide linker |
Zarutatug
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Zarutatug vedotin |
MMAE |
Microtubule (MT) |
Mc-Val-Cit-PABC |
Undisclosed
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
PA-368B |
Undisclosed |
Undisclosed |
Undisclosed |
[6] | |
PA-368A |
Undisclosed |
Undisclosed |
Undisclosed |
[7] |
undisclosed
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
SCR-A008 |
CPT116 |
Undisclosed |
Undisclosed |
[8] | |
BR116 |
Undisclosed |
Undisclosed |
Undisclosed |
[9] | |
SOT109 |
Exatecan |
Undisclosed |
Undisclosed |
[10] |
References
